Rosovsky, Rachel http://orcid.org/0000-0002-2392-7365
Chang, Yuchiao
Rosenfield, Kenneth
Channick, Richard
Jaff, Michael R.
Weinberg, Ido
Sundt, Thoralf
Witkin, Alison
Rodriguez-Lopez, Josanna
Parry, Blair A.
Harshbarger, Savannah
Hariharan, Praveen
Kabrhel, Christopher
Article History
First Online: 21 September 2018
Change Date: 30 November 2018
Change Type: Correction
Change Details: The original version of the article unfortunately contained an error in conflict of interest. This erratum is published with the correct conflict of interest.
Compliance with ethical standards
:
: Chang, Channick, Weinberg, Witkin, Parry, Harshbarger, Hariharan declared that they have no conflict of interest. Rosovsky discloses the following relationships: grant recipient from Bristol Meyer Squibb and Janssen Pharmaceuticals; consultant to Bayer. Rosenfield discloses the following relationships: consultant to: Cardinal Health and SurModics; grants/contracts with Abbott Vascular, Atrium, Lutonix/BARD, and The Medicines Company; equity with Access Closure, Inc., and AngioDynamics/Vortex; personal compensation from Cook, HCRI, and The Medicines Company; board member with VIVA Physicians. Jaff discloses the following relationships: non compensated advisor to Abbott Vascular, Boston Scientific, Cordis, and Medtronic; equity with Vascular Therapies, PQ Bypass, Valiant Medical, and Primacea; board Member with VIVA Physicians (a 501 c 3 not-for-profit education and research). Sundt discloses the following relationship: consultant to Thrasos Therapeutics. Rodriguez-Lopez discloses the following relationships: Grant Support-Actelion pharmaceuticals. Consulting- Gilead pharmaceuticals. Kabrhel discloses the following relationships: consultant to Diagnostica Stago, Janssen Pharmaceuticals, Siemens, Pfizer, and Portola Pharmaceuticals; grant recipient from Diagnostica Stago, Siemens Healthcare, Janssen Pharmaceuticals, and Boehringer-Ingelheim.
: Informed consent was not necessary or obtained as this was part of our program’s quality assurance/quality initiative and was a non interventional study.
: All studies were approved by the Human Research Committee of Partners HealthCare Inc. (2012-P-002257, 2008-P-002001).